86.85
+0.44(+0.51%)
Currency In USD
| Previous Close | 86.41 |
| Open | 87.08 |
| Day High | 87.65 |
| Day Low | 86.02 |
| 52-Week High | 111.45 |
| 52-Week Low | 78.12 |
| Volume | 516,153 |
| Average Volume | 658,122 |
| Market Cap | 5.15B |
| PE | 44.54 |
| EPS | 1.95 |
| Moving Average 50 Days | 84.68 |
| Moving Average 200 Days | 90.32 |
| Change | 0.44 |
If you invested $1000 in Merit Medical Systems, Inc. (MMSI) 10 years ago, it would be worth $4,632 as of December 16, 2025 at a share price of $86.85. Whereas If you bought $1000 worth of Merit Medical Systems, Inc. (MMSI) shares 5 years ago, it would be worth $1,631.6 as of December 16, 2025 at a share price of $86.85.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Merit Medical Provides Update on U.S. Reimbursement and Commercial Strategies for WRAPSODY® Cell-Impermeable Endoprosthesis
GlobeNewswire Inc.
Nov 13, 2025 9:05 PM GMT
SOUTH JORDAN, Utah, Nov. 13, 2025 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a global leader of healthcare technology, announced today that the U.S. Centers for Medicare & Medicaid Services (“CMS”) has notified Merit that its a
Merit Medical Releases 24-Month Efficacy Results from the Randomized Arteriovenous Fistula (AVF) Arm of the WRAPSODY Arteriovenous Access Efficacy (WAVE) Trial
GlobeNewswire Inc.
Nov 05, 2025 2:00 PM GMT
The target lesion primary patency (TLPP)1 and access circuit primary patency (ACPP)2 of the WRAPSODY® Cell-Impermeable Endoprosthesis (CIE) remain superior to percutaneous transluminal angioplasty (PTA) through 24 monthsThe clinical improvements asso
Merit Medical Releases 24-Month Efficacy Results from the Single-Arm Arteriovenous Graft (AVG) Cohort of the WRAPSODY Arteriovenous Access Efficacy (WAVE) Trial
GlobeNewswire Inc.
Nov 03, 2025 2:25 PM GMT
At 24 months, the target lesion primary patency (TLPP)1 was 41.7%At 24 months, the access circuit primary patency (ACPP)2 was 25.7% SOUTH JORDAN, Utah, Nov. 03, 2025 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a global leader of